France · Question · Question écrite
29750
Question 29750 — maternity health insurance
Introduced
—
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
—
Summary
For several years, Elmiron 100 mg was covered on an exceptional and transitional basis within the framework of temporary authorizations for use (ATU) in the indication “interstitial cystitis” then within the framework of cohort ATUs and post ATU. This specialty, due to lack of agreement on its price, has not been included on the list of products and services reimbursed by health insurance. After further exchanges and the laboratory's pricing proposal complies with the pricing criteria, an agreement was finally reached between the economic committee for health products and the laboratory. The publication of the care order for social insurance took place on May 14, 2020, this product is now reimbursed in the city by health insurance. Patient associations were kept informed of these various events and relays to the health professionals who had alerted me to the difficulties of access to this specialty.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/15/questions/QANR5L15QE29750
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L15QE29750